Suppressor genes for malignant and anchorage-independent phenotypes located on human chromosome 9 have no dosage effects

Cytogenetics and Cell Genetics

Volumn 88, Issue 1-2, 2000, Pages 103-109

  Islam, M Quamrul ^a   Islam, K ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GENETICS; CARCINOGENESIS; CELL STRAIN BHK; CHROMOSOME 9; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION 9; CHROMOSOME TRANSLOCATION X; CONTROLLED STUDY; GENE DOSAGE; HUMAN; HUMAN CELL; HYBRID; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SUPPRESSOR GENE;

CRICETINAE; MESOCRICETUS AURATUS; MUS MUSCULUS;

EID: 0034063709     PISSN: 03010171     EISSN: None     Source Type: Journal    
DOI: 10.1159/000015500     Document Type: Article

References (40)

1. Anderson MJ, Casey G, Fasching CL, Stanbridge EJ: Evidence that wild-type TP53, and not genes on either chromosome 1 or 11, controls the tumorigenic phenotype of the human fibrosarcoma HT1080. Genes Chrom Cancer 9:266-281 (1994).
2. RB, the retinoblastoma tumor suppressor protein. Oncogene 10:697-704 (1995).
3. WAF1. Curr Biol 7:71-80 (1996).
4. Benedict WF, Weissman BE, Mark C, Stanbridge EJ: Tumorigenicity of human HT1080 fibrosarcoma × normal fibroblast hybrids: chromosome dosage dependency. Cancer Res 44:3471-3479 (1984).
5. WAF1-derived peptides linked to an internalization peptide inhibit human cancer cell growth. Cancer Res 57:1442-1446 (1997).
6. Bouffler SD, Kemp CJ, Balmain A, Cox R: Spontaneous and ionizing radiation-induced chromosomal abnormalities in p53-deficient mice. Cancer Res. 55:3883-3889 (1995).
7. Chen C, Okayama H: High-efficiency transformation of mammalian cells by plasmid DNA. Mol cell Biol 7:2745-2752 (1987).
8. Chen YN, Sharma KS, Ramsey TM, Jiang L, Martin MS, Baker K, Adams PD, Bair KW, Kaelin Jr WG: Selective killing of transformed cells by cyclin/ cyclin-dependent kinase 2 antagonist. Proc natl Acad Sci, USA 96:4325-4329 (1999).
9. Chin L, Pomerantz J, DePinho RA: The INK4a/ARF tumor suppressor: one gene-two products-two pathways. Trends Biol Sci 23:291-296 (1998).
10. Cirielli C, Riccioni T, Yang C, Pili R, Gloe T, Chang J, Inyaku K, Passaniti A, Capogrossi MC: Adenovirus-mediated gene transfer of wild-type p53 results in melanoma cell apoptosis in vitro and in vivo. Int J Cancer 63:673-679 (1995).
11. Davidson RL: Regulation of melanin synthesis in mammalian cells: effect of gene dosage on the expression of differentiation. Proc natl Acad Sci, USA 69:951-955 (1972).
12. Davidson RL: Gene expression in somatic cell hybrids. A Rev Genet 8:195-218 (1974).
13. Evans EP, Burtenshaw MD, Brown BB, Hennion R, Harris H: The analysis of malignancy by cell fusion. IX, Re-examination and clarification of the cytogenetic problem. J Cell Sci 56:113-130 (1982).
14. Fåhraeus R, Lain S, Ball KL, Lane DP: Characterization of the cyclin-dependent kinase inhibitory domain of the INK4 family as a model for a synthetic tumor suppressor molecule. Oncogene 16:587-596 (1998).
15. CDKN2/INK4A. Curr Biol 6:84-91 (1995).
16. Fearon ER: Human cancer syndromes: clues to the origin and nature of cancer. Science 278:1043-1050 (1997).
17. Fero ML, Randel E, Gurley KE, Roberts JM, Kemp CJ: The murine gene p21kip1 is haplo-insufficient for tumor suppression. Nature 396:177-180 (1998).
18. Fougere C, Ruiz F, Ephrussi B: Gene dosage dependence of pigment synthesis in melanoma × fibroblast hybrids. Proc Natl Acad Sci, USA 69:330-334 (1972).
19. Gomez-Manzano C, Fueyo J, Kyritsis AP, Steck PA, Roth JA, McDonnell TJ, Steck KD, Levin VA, Yung WKA: Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis. Cancer Res 56:694-699 (1996).
20. Hamon-Benais C, Delagebeaudeuf C, Jeremiah S, Lecoq O, Cassio D: Efficiency of a specific albumin extinguisher locus in monochromosomal hepatoma hybrids. Expl Cell Res 213:295-304 (1994).
21. Harris H: The analysis of malignancy by cell fusion: the position in 1988. Cancer Res 48:3302-3306 (1988).
22. Harris H: How tumor suppressor genes were discovered. FASEB J 7:978-979 (1993).
23. Harris H, Miller OJ, Klein G, Worst P, Tachibana T: Suppression of malignancy by cell fusion. Nature 223:363-368 (1969).
24. Islam K, Islam MQ: Assignment of TK1 encoding thymidine kinase to Syrian hamster chromosome 9 by microcell-mediated chromosome transfer. Cytogenet Cell Genet 66:177-180 (1994).
25. Islam MQ, Islam K, Levan G, Horvath G: Monochromosome transfers to Syrian hamster BHK cells via microcell fusion provide functional evidence for suppressor genes on human chromosome 9 both for tumorigenicity and for anchorage independence. Genes Chrom Cancer 13:115-125 (1995).
26. Jacks T, Shin TS, Schmitt EM, Bronson RT, Bernards A, Weinberg RA: Tumor predisposition in mice heterozygous for a targeted mutation in NF1. Nature Genet 7:353-361 (1994).
27. INK4 gene mediated by an adenovirus vector. Cancer Res 55:3250-3253 (1995).
28. Marshall CJ: Tumor suppressor genes. Cell 64:313-326 (1991).
29. McClatchey Al, Saotome I, Mercer K, Crowley D, Gusella JF, Bronson RT, Jacks T: Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly melastatic tumors. Genes Dev 12:1121-1133 (1998).
30. Nachtigal MW, Hirokawa Y, Enyeart-Van Houten DL, Flanagan JN, Hammer GD, Ingraham HA: Wilms' tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression. Cell 93:445-454 (1998).
31. Pagliaro LC, Antelman D, Johnson DE, Machemer T, McCulloch EA, Freireich EJ, Stass SA, Shepard HM, Maneval D, Gutlerman JU: Recombinant human retinoblastoma protein inhibits cancer cell growth. Cell Growth Diff 6:673-680 (1995).
32. Polakis P: The adenomatous polyposis coli (APC) tumor suppressor. Biochim biophys Acta 1332: F127-147 (1997).
33. Saxon PJ, Srivatsan ER, Stanhridge EJ: Introduction of human chromosome II via microcell transfer controls tumorigenic expression of HeLa cells. EMBO J 5:3461-3466 (1986).
34. Sekiguchi T, Hunter T: Induction of growth arrest and cell death by overexpression of the cyclin-Cdk inhibitor p21 in hamster BHK21 cells. Oncogene 16:369-380 (1998).
35. Tang B, Böttinger EP, Jakowlew SB, Bagnall KM, Mariano J, Anver MR, Letterio JJ, Wakefield LM: Transforming growth factor-β1 is a new form of tumor suppressor with true haploid insufficiency. Nature Med 4:802-807 (1998).
36. Venkatachalam S, Shi YP, Jones SN, Vogel H, Bradley A, Pinkel D, Donehower LA: Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation. EMBO J 17:4657-4667 (1998).
37. Walker GJ, Flores JF, Glendening JM, Lin A, Markl IDC, Fountain J: Virtually 100% of melanoma cell lines harbor alterations at the DNA level within CDKN2A, CDKN2B, or one of their downstream targets. Genes Chrom Cancer 22:157-163 (1998).
38. KIP1 overexpression causes apoptotic death of mammalian cells. Oncogene 15:2991-2997 (1997).
39. Yang C, Cirielli C, Capogrossi MC, Passaniti A: Adenovirus-mediated wild-type p53 expression induces apoptosis and suppresses tumongenesis of prostate tumor cells. Cancer Res 55:4210-4213 (1995).
40. Yeung RS, Xiao GH, Everitt JI, Jin F, Walker CL: Allelic loss at the tuberous sclerosis 2 locus in spontaneous tumors in the Eker rat. Mol Carcinogen 14:28-36 (1995).